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 The Osteogenic Potential of the 
Neural Crest Lineage May Contribute 
to Craniosynostosis 
 Daniel Doro    Annie Liu    Agamemnon E. Grigoriadis    Karen J. Liu 
 Centre for Craniofacial and Regenerative Biology, King’s College London,  London , UK
 
 Craniosynostosis (CS), the premature fusion of the 
cranial sutures, is a widely prevalent congenital malfor-
mation, affecting, on average, 1 in 2,000–2,500 live births 
[Boulet et al., 2008]. The head in children with CS is often 
deformed, as a consequence of the compensatory growth 
at the remaining patent sutures, in an effort to accommo-
date the expanding brain [Morriss-Kay and Wilkie, 2005]. 
In most cases, the anomalies are isolated (nonsyndrom-
ic); however, approximately 25% of the defects are associ-
ated with over 180 different sydromes [Kimonis et al., 
2007; Greenwood et al., 2014]. In addition to the cranial 
and facial dysmorphisms that result from CS, other mor-
bidities include increased intracranial pressure, potential 
developmental delay and, often, cognitive impairment 
[Kimonis et al., 2007]. Nonsyndromic CS is multifacto-
rial and most commonly affects the patency of sagittal or 
coronal sutures [Hunter and Rudd, 1976, 1977]. Metopic, 
lambdoid, or multiple suture fusion accounts for less than 
25% of nonsyndromic cranyosinostosis [Lajeunie et al., 
1998].
 Previous lineage tracing studies have described a pre-
dominance of neural crest-derived mesenchyme in the 
large majority of the cranial sutures [Jiang et al., 2002; 
Yoshida et al., 2008; Wu et al., 2017]. Importantly, the 
maintenance of an undifferentiated and unossified mes-
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 Abstract 
 The craniofacial skeleton is formed from the neural crest and 
mesodermal lineages, both of which contribute mesenchy-
mal precursors during formation of the skull bones. The large 
majority of cranial sutures also includes a proportion of neu-
ral crest-derived mesenchyme. While some studies have ad-
dressed the relative healing abilities of neural crest and me-
sodermal bone, relatively little attention has been paid to 
differences in intrinsic osteogenic potential. Here, we use 
mouse models to compare neural crest osteoblasts (from 
frontal bones or dura mater) to mesodermal osteoblasts 
(from parietal bones). Using in vitro culture approaches, we 
find that neural crest-derived osteoblasts readily generate 
bony nodules, while mesodermal osteoblasts do so less ef-
ficiently. Furthermore, we find that co-culture of neural 
crest-derived osteoblasts with mesodermal osteoblasts is 
sufficient to nucleate ossification centres. Altogether, this 
suggests that the intrinsic osteogenic abilities of neural 
crest-derived mesenchyme may be a primary driver behind 
craniosynostosis.  © 2018 The Author(s)
Published by S. Karger AG, Basel 
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enchyme is required for suture patency and often coin-
cides with the establishment of a neural crest/mesoderm 
boundary, as clearly observed in the coronal suture, where 
frontal and parietal bones meet [Merrill et al., 2006]. 
Moreover, abnormal proliferation and premature differ-
entiation of the sutural mesenchyme are likely the most 
important cellular mechanisms leading to CS [Iseki et al., 
1999]. These biological events are tightly regulated by in-
tricate signalling pathways, originating from adjacent tis-
sues with regional and temporal control over the suture 
fusion sequence [Bradley et al., 1996]. For instance, the 
underlying dura mater has been implicated in specific de-
termination of suture patency and ossification [Levine et 
al., 1998; Greenwald et al., 2000].
 Rodents have been repeatedly used as a model for pre-
mature fusion of cranial sutures. Interestingly, only the 
posterior part of the frontal suture in mice fuses in early 
postnatal life, while all other cranial sutures remain pat-
ent throughout life [Bradley et al., 1996]. Further studies 
in rats showed that a simple change of location to where 
the posterior frontal suture originally lies was enough to 
induce the fusion of the sagittal sutures. The frontal su-
ture, when transplanted to the anatomical position of the 
sagittal suture, remained patent as the latter would [Levine 
et al., 1998]. The expression of osteogenic markers was 
potently upregulated in the dura mater underlying the 
closing posterior frontal suture, whereas the dura mater 
cells under the patent sutures show significantly increased 
proliferation [Greenwald et al., 2000]. The dura mater 
underlying the coronal suture was shown to be important 
for maintenance of patency as removal of the membrane 
results in osseous obliteration in coronal suture trans-
plants [Opperman et al., 1993]. All together, these studies 
suggest that not only does the dura mater directly con-
tribute osteoprogenitors to the ossification of the frontal 
suture, but the meninx juxtaposed to the cranial bones 
also provides regionally specified signals capable of in-
ducing fusion of normally closing sutures or maintenance 
of patency in certain areas. The investigation of molecular 
events involved in physiological suture fusion is funda-
mental to the understanding of pathological premature 
obliteration as seen in CS anomalies.
 Dysfunctional suture fusion regulation performed by 
the dura mater has been previously proposed as an under-
lying cause for congenital CS. Specifically, a colony of rab-
bits that models CS had the synostosed suture osteoto-
mized and a patent suture transplanted to the site of the 
defect. The fusion of this suture was prevented by isolat-
ing the transplant from the underlying dura mater with 
an impermeable material, whereas synostosis occurred 
when no barrier was inserted [Cooper et al., 2012]. This 
suggests that the CS-inducing signal was coming from the 
underlying dura mater and not from the cranial bones or 
the sutures. Other studies have implicated fibroblast 
growth factor as one amongst many potential dura mater-
derived signals responsible for causing CS [Ang et al., 
2010]. Nonetheless, the origins and mechanisms behind 
CS as well as the osteogenic abilities of the distinct cra-
nial populations still remain poorly understood.
 Here, we investigate the in vitro osteogenic capabilities 
of the distinct populations in the cranial complex, hy-
pothesizing that the intrinsic potential of cells from dif-
ferent embryonic origins correlates with the potential for 
CS. Ectopic suture fusion in ciliopathic mice, for instance, 
has been previously associated with aberrant expansion 
of the neural crest-derived tissues at the expense of meso-
dermal bones [Tabler et al., 2016]. Utilizing neural crest-
specific lineage tracing techniques, we compared the 
bone forming ability of frontal and dura mater osteopro-
genitors to mesodermally derived parietal cells.
 Materials and Methods 
 Animal Procedures 
 Mouse strains:  Wnt1-Cre [Danielian et al., 1998],  Mesp1-Cre 
[Saga et al., 1999],  Rosa26R mTmG [Muzumdar et al., 2007], or 
 Rosa26 Tomato [Madisen et al., 2010] mouse lines have all been de-
scribed previously. Genotyping was performed as described in 
original publications. All the mouse lines have been bred on a 
mixed background, unless otherwise noted.
 Cryosectioning 
 Postnatal day 0 (PN0) mouse heads were harvested at birth. 
The samples were then fixed in 4% paraformaldehyde for 48 h at 
4  °  C. After 3 PBS washing steps, the heads were embedded in opti-
cal cutting temperature (OCT) compound (CellPath ® ) in 3 steps. 
First, the samples were moved to a 30% sucrose solution in PBS 
( ∼ 24 h). Then, the embedding solution was replaced with a 30% 
sucrose solution mixed with OCT compound (1: 1) and incubated 
at 4   °   C. Finally, the samples were moved and oriented in a plastic 
Tissue-Tek ® Cryomold ® filled with OCT compound. The mold 
was quickly moved into a dry ice bath with absolute ethanol until 
the OCT block was fully solidified. OCT-embedded samples were 
stored at –80   °   C and reconditioned to –26   °   C, inside the cryostat 
chamber, 30 min prior to sectioning. Cryosections were performed 
using OFT5000 ® cryostat microtome (BrightInstruments ® ). 25 
μm sections were immediately mounted into Superfrost Ultra 
Plus ® slides (ThermoScientific ® ), which were then stored at room 
temperature for future use.
 Primary Cell Harvest 
 Dissections of postnatal calvaria were performed in PBS. Dura 
mater and periosteum were removed with a forceps prior to dis-
section of frontal and parietal. The sutures were trimmed off with 
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micro scissors to avoid any mixing of the bone osteoblasts with 
mesenchymal progenitor populations. The mineralized matrix 
was then digested for 10 min with 0.5% Trypsin (Sigma-Aldrich), 
20 min with 2 mg/mL Dispase II (Roche) in Hank’s Balanced Salt 
Solution (HBSS) (Gibco ® ) and 2× 30 min with 2 mg/mL Collage-
nase (Sigma-Aldrich) in HBSS. Each of the collagenase digestion 
steps was collected into tubes containing equivalent amount of 
FBS. After neutralization with FBS and mild centrifugation (1,000 
rpm), the cell pellet was resuspended in 10 mL of osteoblast culture 
media (see formula below) and plated into 10 cm 2 dishes. Plates 
were incubated at 37  °  C and 5% CO 2 .
 Dura mater and interfrontal suture (IFS) cells were obtained by 
plating pooled dissected dura mater membranes, or IFS, after 10 
min digestion with 0.5% Trypsin. The tissue was then incubated at 
37  °  C and 5% CO 2 in osteoblast culture media. 
 Fluorescence-Activated Cell Sorting 
 Single calvariae, devoid of periosteum and dura mater, were 
digested according to the protocol above, and the first and second 
collagenase pools were collected into tubes with FBS for neutral-
ization. After centrifugation at 1,000 rpm, the pellet was resus-
pended in 500 μL of PBS supplemented with 5% of FBS. The sus-
pension obtained was pipetted through 40 μm tip strainers (Flow-
mi TM ) to obtain a single-cell suspension. The mixed membrane 
GFP (mGFP) and membrane Tomato (mT) cell suspension was 
then sorted into green and red populations using BD FACS TM Aria 
II sorter (BD ® Biosciences).
 Cell Culture 
 Osteoblast Culture Medium 
 The osteoblast culture medium consisted of Minimum Essen-
tial Medium Eagle Alpha Modification (Alpha-MEM) with Ultra-
GlutamineTMI, deoxyribonucleosides, and ribonucleosides (Lon-
za ® ); 10% batch tested FBS, and Antibiotic-Antimycotic (Gibco).
 Osteogenic Medium 
 The osteogenic medium contained Alpha-MEM (Lonza), 10% 
batch tested FBS, Antibiotic-Antimycotic (Gibco), 0.25 m M ascor-
bic acid (Sigma), and 5 m M β-glycerophosphate (Invitrogen ® ).
 Alkaline Phosphatase Staining 
 Alkaline phosphatase (ALP) activity was detected after fixation 
of the cultured cells with 10% paraformaldehyde. After 3 PBS 
washes, the culture plates were incubated for 1 h at room temper-
ature in ALP staining solution: Sigma-Aldrich Fast Red Violet LB 
Salt (60 mg) (Sigma) and Naphtol AS-Mx-PO4 (10 mg) (Sigma) in 
0.1  M Tris pH 8.3 (100 mL).
 Von Kossa Staining 
 Von Kossa staining was used for detection of mineralized nod-
ules after fixation in paraformaldehyde and ALP staining. After 3 
ddH 2 O washes, the culture plates were incubated in 2.5% of silver 
nitrate in water for 1 h under UV exposure (252 nm).
 Microscopy and Image Analysis 
 A stereoscope (Nikon SMZ1500) with an attached camera 
(Nikon digital sight DS-Fi1) was used to take all the whole mount 
pictures and fluorescent pictures at low magnification (as indi-
cated). Confocal microscopy was performed on a Leica Microsys-
tems CMS GmbH TCS SP5 DM16000. Image sequences were re-
constructed using FIJI (Image J) analysis software. Pixel density 
analysis of the staining was performed using the Analyze Particles 
function under the menu Analyse in the Image J software. This 
analysis is only possible after adjusting the threshold of the binary 
image created. The cell counts were performed using the plugin 
Cell Counter available on the Image J website.
 Statistical Analysis 
 p values were determined using multiple unpaired  t test analy-
sis in the GraphPad Prism 7 Software. Every cell culture experi-
ment was performed in triplicate (3 wells each from cells isolated 
from pooled animals), unless otherwise noted.
 Results 
 Wnt1-cre Driver Identifies the Different Embryonic 
Origins of the Cranial Components 
 The embryonic origins of the mammalian skull have 
been previously mapped using the neural crest-specific 
 Wnt1-cre driver and the  Rosa26R lacZ reporter [Jiang et al., 
2002; Wu et al., 2017]. To assess in detail the neural crest 
and mesodermal contributions to the cranial complex, we 
analyzed newborn pups (PN0) using the neural crest-spe-
cific  Wnt1-cre driver in association with a  Rosa26 mTmG 
reporter. In these mice, cells ubiquitously express an mT 
marker. Upon expression of the Cre recombinase, cells 
switch from expression of mT to mGFP specifically in 
neural crest tissues. We confirmed that most of the cra-
niofacial skeleton expressed mGFP, indicating derivation 
from the neural crest lineage; one exception is the parietal 
bones, which continue to express mT ( Fig. 1 A, B). As we 
dissected the cranial vault, we saw a predominant neural 
crest contribution to the sagittal suture, contrasting to a 
mixed contribution from neural crest and mesoderm to 
the coronal suture, where frontal and parietal bones meet 
( Fig. 1 C, D). A closer look at the coronal suture reveals a 
clear neural crest-mesoderm boundary between frontal 
and parietal bones, which is underlined by a fully neu-
ral crest-derived dura mater. The overlying periosteum 
appears to be of mixed embryonic origin ( Fig.  1 E). 
In the original study describing compound  Wnt1-cre; 
Rosa26R lacZ embryos, expression of beta-galactosidase is 
seen in migrating neural crest cells and their mature de-
rivatives as well as in parts of the neural tube giving rise 
to the midbrain and the hindbrain [Jiang et al., 2000]. 
Coronal sections of E17.5 heads in a later study confirmed 
that the frontal, but not the parietal bones were stained 
positive with beta-galactosidase substrate, X-gal [Jiang et 
al., 2002]. Moreover, the meninges, including the dura 
mater, were positive for X-gal around the cerebral cortex, 
but not the meninges overlying the midbrain and the 
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hindbrain. This is difficult to distinguish in sagittal sec-
tions in our  Wnt1-cre; Rosa26 mTmG mice; however, con-
tribution of mesodermal derivatives confirmed these ob-
servations (see below, online suppl. Fig. 1; for all suppl. 
material, see www.karger.com/doi/10.1159/000493106).
 Because non-neural crest tissues (ectoderm, meso-
derm, and endoderm) could not be distinguished using 
the  Wnt1-cre genetic model, we also confirmed the me-
sodermal origin of the parietal bones using the meso-
derm-specific  Mesp1-cre driver. The original study de-
scribing this model, showed the neural crest origin of the 
meninges underlying the frontal and parietal bones [Yo-
shida et al., 2008]. However, this study revealed mesoder-
mal contribution to the meninges underlying the interpa-
rietal bone. Indeed, when we looked at our  Mesp1-cre; 
Rosa26 mTmG model, we saw mesodermal contribution 
(green) to the meninges overlying the posterior regions 
of the brain, including the cerebellum (online suppl. 
Fig. 1E).
 One caveat with these lineage-labelling experiments is 
the possibility that the  cre transgenes may be expressed in 
non-neural crest tissues either due to additional domains 
of  Wnt1-cre expression, through insertion site effects of 
the transgene, through leakiness, or other effects. For ex-
ample, the  Wnt1-cre  transgene is expressed at the mid-
hindbrain boundary during neurulation; therefore, it 
would be incorrect to state definitively that all  Wnt1-cre 
positive cells are neural crest. We also cannot ensure that 
every neural crest cell is captured by these reporters, as 
expression of the  Wnt1-cre transgene only begins as the 
neural crest cells are being induced. Transgenic lines can 
also have ectopic effects, which are difficult to predict 
[Lewis et al., 2013]. Nevertheless, by combining micro-
dissection with genetic labelling/ fluorescence-activated 
cell sorting, we are confident that our populations are as 
pure as technically possible.
 We then confirmed the distinct origins of the cranial 
components by enzymatically isolating cells from the 
postnatal bones and dura mater (PN0). After 1 day of cul-
ture, dura mater cells are more dense and elongated, 
whereas frontal bone cells appear more widely spread and 
sparse. These cells were isolated from the explants dis-
played in  Figure 1 C, where the tissue posterior to the pa-
rietal bones is removed, which explains why our dura ma-
G HF
EBA
DC
 Fig. 1.  Wnt1-cre recombination labels neural crest-derived tissues 
in the cranial vault.  A–D Whole mount views of newborn (PN0) 
 Wnt1-cre; Rosa26R mTmG  tissues.  A Side view of the whole animal 
reveals predominant neural crest origin (green) of the craniofacial 
structure with exception of the parietal region (arrow), which is 
mesodermally derived. All non-neural crest tissues appear in red. 
 B Top view of the head shows neural crest-mesoderm boundary 
(dashed line) between frontal and parietal bones. Neural crest con-
tribution (green) is also seen at the interparietal bone and on the 
midline between paired parietals.  C ,  D Dissected cranial vaults with 
adjacent membranes intact ( C ) or after periosteum and dura mater 
removal ( D ) reveal the neural crest origin (green) of frontal bone 
and the whole sagittal suture and mesodermal contribution (red) of 
parietal bones and part of the coronal suture.  E Sagittal section at 
the coronal suture shows the neural crest-mesoderm boundary in 
detail ( Inset ). The neural crest frontal bone overlaps the mesoder-
mally derived parietal (dashed lines) at the coronal suture, whereas 
dura mater is exclusively neural crest.  F ,  G Primary cells isolated 
from dissected calvarial tissues and cultured for 24 hours. Dura ma-
ter ( F ) and frontal bone cells ( G ) are neural crest derived (green) 
and parietal cells ( H ) are mesodermal in origin (red). c, coronal su-
ture; f, frontal; ip, interparietal; p, parietal; s, sagittal suture. 
 Doro/Liu/Grigoriadis/Liu
 
 Mol Syndromol 2019;10:48–57 
DOI: 10.1159/000493106
52
ter cell cultures were almost exclusively neural crest de-
rived ( Fig.  1 F). Parietal bone cells resemble the 
morphology of frontal cells, although the well with the 
former was more densely populated and the cells smaller 
in size. ( Fig.  1 G, H). Although pure populations were 
rarely obtained when dissecting calvarial tissues, dura 
mater and frontal bone cells were largely green, while pa-
rietal cells were red ( Fig. 1 ). Using this approach, these 
populations could be easily sorted according to their em-
bryonic origins (online suppl. Fig. 2).
 Neural Crest-Derived Dura Mater Cells Are More 
Osteogenic in Culture than Frontal or Parietal 
Osteoprogenitors 
 To investigate the osteogenic potential of the isolated 
cell populations, we cultured them at the same plating 
densities in osteogenic media. Fourteen days after plat-
ing, we observed the formation of mineralized nodules 
with intense ALP activity in the dura mater cells ( Fig. 2 A; 
online suppl. Fig. 4A). Cells derived from frontal and pa-
rietal bones, on the other hand, do not make any nodules 
or aggregates at this stage ( Fig. 2 B, C). This is accompa-
nied by significantly lower ALP activity, as assessed by the 
density of the staining ( Fig. 2 G). The fluorescence of the 
cells in culture revealed that while dura mater cells are in 
a stage of aggregation and nodule formation ( Fig. 2 D), 
frontal cells are still sparsely distributed, and parietal cells 
are even more sparse and lower in density ( Fig. 2 E, F). 
This suggests that dura mater cells in culture have in-
creased osteogenic potential in comparison to bone-de-
rived osteoprogenitors. Moreover, a higher density and 
presence of aggregates in these cultures indicate an ad-
vanced stage of osteogenic differentiation, suggesting that 
frontal cells are at an intermediate stage between parietal 
cells and dura mater cells. Importantly, our criterion to 
determine the osteogenic potential is based on a stan-
dardized in vitro assay, which is the presence of mineral-
ized nodules after a long period of osteogenic differentia-
tion. While the increased mineralization could indeed be 
a feature of the specific cell in question, as it secretes un-
ossified matrix and induces mineral deposition, it is also 
possible that the presence of more bony nodules is a con-
sequence of increased proliferation in the earliest stages 
of culture, when the cells are expanding to confluency. 
One possibility is that cranial sub-populations isolated 
from the same animal reflect a difference in differentia-
tion stage. However, regardless of the timing of isolation 
(e.g., embryonic stages vs. newborn or later stages, data 
A B C G
D E F
 Fig. 2. Dura mater cells are more osteogenic in vitro than osteo-
progenitors from the cranial vault bones.  A–C Alkaline phospha-
tase (ALP) (red) and Von Kossa (black) staining of PN0 cultured 
cells after 14 days in osteogenic media.  A Dura mater cells were 
capable of making ALP positive, mineralized, bony nodules (ar-
row), whereas frontal ( B ) and parietal ( C ) cells are still sparse and 
ungrouped at this stage.  D–F mGFP and mT fluorescent cells in 
higher magnification (Hoechst – nuclei).  D Dura mater green cells 
are grouped in nodule-like structure (arrow).  E Frontal cells, al-
though sparsely distributed, are more confluent than parietal cells 
( F ) at this stage.  G ALP activity from calvarial cells as measured by 
pixel density quantification of the red staining in A–C. Dura cells 
accordingly show significantly higher ALP activity when com-
pared to frontal and parietal cells. DM, dura mater; FB, frontal 
bone; PB, parietal bone.  *  p <  0.05. 
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not shown),  Wnt1-cre positive osteoblasts appear more 
osteogenic, arguing against a shift in the timing of osteo-
blast maturation and favouring a model where the dura 
mater, frontal and parietal populations each contain dif-
fering proportions of osteoblast precursors.
 Neural Crest-Derived Frontal Osteoprogenitors Are 
More Osteogenic than Mesoderm-Derived Parietals in 
Culture 
 To further confirm the increased potential of frontal 
bone cells over parietal cells, we cultured these popula-
tions at equivalent plating densities in osteogenic media 
for 21 days. This was enough to yield numerous mineral-
ized frontal nodules, but very little mineralization of pa-
rietal cells ( Fig. 3 A, B). Indeed, the mineralized area was 
significantly higher in the former as assessed by the den-
sity of (black) Von Kossa staining ( Fig.  3 E). While the 
neural crest- and mesoderm-derived cells can be sorted 
en masse as previously shown, we generally opted to rely 
on the manual dissection of the tissues to ensure minimal 
disruption to the cells. For that reason, there is occasion-
ally the presence of neural crest-derived cells in parietal 
osteoblast cultures and vice versa. Even a small number 
of these contaminants is capable of expanding to a sig-
nificant proportion of the total number of cells, leading 
to the presence of numerous red cells mixed with green 
cells and vice versa (see  Fig. 3 C, D). Nonetheless, although 
the frontal bone cultures also contained cells of non-neu-
ral crest origin, nodules seen at 21 days were formed pre-
dominantly from neural crest-derived progenitors 
( Fig. 3 C). Interestingly, in the reciprocal experiment, the 
few nodule-like structures found in cultures of parietal 
cells appeared mostly green ( Fig.  3 D), suggesting a re-
quirement of neural crest-derived progenitors for forma-
tion of condensations in culture of parietal cells. Fortu-
itously, this raises the hypothesis that parietal cells are 
generally incapable or inefficient at making bony nodules 
in vitro. As these cells can ossify efficiently in vivo ,  it is 
likely that they are receiving pro-osteogenic signals from 
the adjacent neural crest.
A B
C D
E
 Fig. 3. Neural crest frontal bone cells are more osteogenic in vitro 
than mesodermally derived parietal cells.  A ,  B Alkaline phospha-
tase (ALP; brown) and Von Kossa (black) staining of PN0 frontal 
and parietal cells after 21 days in osteogenic media. While frontal 
cells were largely capable of making mineralized nodules ( A ), cells 
isolated from the parietal bone show little mineralization and nod-
ule formation ( B ).  C ,  D mGFP and mT fluorescent cells in higher 
magnification (Hoechst – nuclei).  C Even with the presence of 
non-neural crest contaminants (red cells) in the frontal cells cul-
ture, the mineralized nodules (red outline) are mostly made of 
neural crest-derived cells (green).  D The rarely found nodules (yel-
low outline) in parietal cells culture seem to be made from neural 
crest contaminants.  E Mineralized area of frontal and parietal cell 
cultures, as measured by pixel density quantification of black stain-
ing in A and B. Frontal bone cells yield significantly more mineral-
ized cultures than parietal cells. FB, frontal bone; PB, parietal bone. 
 * * * p < 0.001. 
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 Co-Culture with Neural Crest-Derived Cells Favours 
in vitro Osteogenesis of Parietal Osteoblasts 
 We next set out to test whether co-culturing of neural 
crest-derived cells and parietal progenitors at equivalent 
plating densities would produce bony nodules with mixed 
contributions. We observed that, after 14 days of culture, 
dura mater/parietal co-culture yielded intense ALP activ-
ity and a large number of nodules ( Fig. 4 A; online suppl. 
Fig.  5A). These nodules were mostly of mixed neural 
crest/mesoderm origin with no particular bias, although 
fluorescent labelling revealed that they appear to be nu-
cleated by the green neural crest cells, which are slightly 
more abundant in dura mater/parietal cell cultures 
( Fig. 4 C; online suppl. Fig. 3 for quantification). More-
over, the culture of frontal bone cells with parietal cells 
resulted in vast mineralization and abundance of bony 
nodules after 21 days ( Fig. 4 B). Accordingly, these nod-
ules were not skewed towards neural crest nor mesoder-
mal cells (online suppl. Fig. 4), although the base of the 
nodules was mostly formed by green cells ( Fig. 4 D). This 
was in contrast to the absence of mesodermally derived 
nodules in culture of isolated parietal cells (compare 
 Fig. 4 D and  Fig. 3 D). A limitation of our analysis was that 
the ALP and Von Kossa staining masked the fluorescence 
of the cells, such that the imaging of nodules and their cell 
content had to be performed prior to the staining proce-
dure. Nonetheless, it would be interesting to quantify the 
proportion of neural crest and mesoderm cells that are 
also positive for ALP. Immunostaining assays will be 
done in the future to address this further.
 All together, our study indicates that although meso-
dermally derived parietal osteoprogenitors seem to lack 
the ability to efficiently make nodules in culture, they are 
able to contribute to the formation of these structures 
when co-cultured with cells of neural crest origin, which 
seem to nucleate the bony nodules. This raises the need 
to further investigate potential signals between calvarial 
cells of distinct embryonic origins to improve our under-
standing of the molecular signalling at the neural crest-
mesoderm boundary in the skull.
 Dura Mater Cells Are the Most Osteogenic amongst 
Neural Crest-Derived Cranial Progenitors 
 In light of the higher propensity for osteogenesis dis-
played by the neural crest tissues in the cranial vault, we 
decided to investigate which of the site-specific progeni-
tors would show higher osteogenic activity in vitro. PN10 
osteoblasts were harvested from 3 distinct locations in 
 Wnt1-Cre; Rosa26 Tomato mice (see schematics on  Fig. 5 K) 
and cultured for 21 days in osteogenic conditions. At day 
A B
C D
 Fig. 4. Parietal bone cells can contribute to 
nodule formation as long as they are co-
cultured with neural crest-derived cells. 
 A ALP/Von Kossa staining of equivalently 
mixed dura mater and parietal cells reveal 
presence of mineralized nodules (arrow) 
after 14 days of culture in osteogenic me-
dia.  B ALP/Von Kossa staining of frontal 
and parietal mixed cultures; after 21 days in 
osteogenic media they are largely mineral-
ized (black staining, arrow).  C mGFP/mT 
fluorescence reveals mixed neural crest 
(green) and mesoderm (red) contribution 
for nodule (outline) formation (Hoechst – 
nuclei).  D mTmG fluorescence reveals 
neural crest (green) and mesoderm (red) 
mixed contribution for nodule formation 
(yellow outline). 
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21, we find that dura mater cells are denser and possess 
significantly higher ALP activity when compared to cells 
from IFS and frontal bone osteoblasts ( Fig.  5 J). These 
cells also produce more mineralized nodules than the lat-
ter (online suppl. Fig. 5B) and in larger size ( Fig. 5 G–I). 
The presence of mineralized nodules is comparable be-
tween IFS cells and frontal bone osteoblasts (online sup-
pl. Fig. 5B). However, the higher area of ALP staining 
indicates that frontal bone cultures have more progeni-
tors committed to the osteogenic pathway, which are ac-
tively making bone in vitro  ( Fig. 5 A–C). This might re-
flect an expected delay in the differentiation stage, given 
that a proportion of the sutural mesenchyme is still un-
committed when harvested from the explants, whereas 
the cells harvested from the bone chips are likely fully 
differentiated at this postnatal stage. While it is true that 
the sutural mesenchyme harbours numerous undifferen-
tiated stem cells with multi-lineage potential [for review, 
see Doro et al., 2017], it is possible that, in vitro ,  these 
cells require exogenous signalling input to undergo os-
teogenesis. In addition, it would be interesting to know 
the dura mater requirements for ossification of the su-
tural cells.
 Discussion 
 The embryonic origins of the cranial components are 
often neglected in studies using primary cell cultures for 
osteogenic assays. While heterogenous populations iso-
lated from whole calvaria have been largely used for in 
vitro differentiation assays, the bone forming ability of 
calvarial osteoprogenitors appears to be site and lineage 
specific. Each tissue in the cranial vault harbours distinct 
osteogenic capacity, being implicated in different roles 
during development and likely having distinct contribu-
tions to bone diseases and malformations. One classic ex-
ample is the investigation of the pathogenesis of CS.
 Although the premature ossification of a sutural mes-
enchyme may ultimately influence multiple tissues of dis-
A B C J
K
D E F
G H I
 Fig. 5. Dura mater cells are the most osteogenic amongst neural 
crest-derived cranial populations.  A–C ALP/Von Kossa staining 
of primary cells from dura mater, interfrontal suture and fron-
tal bone, respectively. Arrows indicate mineralized nodules. 
 D–F Contrast phase high magnification nodules reveal 3D-miner-
alized structure surrounded by a monolayer of cells.  G–I Tomato 
fluorescence reveals neural crest origin of the Dura, interfrontal 
suture (IFS), and frontal bone (FB) populations. The nodules out-
lined are increased in size in dura cell cultures.  J Pixel density 
quantification of ALP staining shows significantly increased activ-
ity of dura cells when compared to IFS and FB cells, the latter is 
also significantly higher than in IFS cells.  K Schematics show sites 
of harvesting where the cells originated from. DM, dura mater; IF, 
interfrontal; FB, frontal bone.  *  p < 0.05;  * * p < 0.005. 
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tinct embryonic origins, it is still unclear which specific 
cell populations are the primary drivers of pathogenesis. 
Rather, as studies have shown, the dura mater seems to be 
the major player behind the suture patency, or fusion, 
during skull development. Either by providing molecular 
signals, or by directly contributing osteoprogenitors that 
undergo differentiation, the underlying dura mater may 
determine whether a cranial suture fuses or remains pat-
ent [Mehrara et al., 1999; Greenwald et al., 2000; Warren 
et al., 2003]. This membrane is regionally specified and 
can sometimes undergo aberrant differentiation, causing 
severe consequences for the adjacent tissue, as in CS [Ang 
et al., 2010; Cooper et al., 2012], or even undergo tumor-
igenesis as seen in meningeal osteosarcomas [Bonilla et 
al., 1994; Ringenberg et al., 2000]. The understanding of 
the osteogenic potential and its correlation with the dis-
tinct embryonic origins is therefore fundamental for the 
comprehension of CS and may reveal a propensity of neu-
ral crest-derived tissues to undergo hyperossification.
 As we have reproduced in this study using genetic la-
belling and lineage tracing, the dura mater is exclusively 
neural crest derived, as are the frontal bones. Even though 
the parietal bones are derived from the mesoderm, all the 
cranial sutures including the coronal are thought to be 
predominantly populated by neural crest osteoprogeni-
tors. We have shown that the dura mater-derived cells are 
much more osteogenic in vitro than the osteoblasts har-
vested from frontal or parietal bones. This was revealed 
by an increased ALP activity and the prompt generation 
of bony nodules in dura mater cell cultures. Moreover, 
the osteoblasts derived from neural crest frontal bones 
showed significantly increased in vitro osteogenesis when 
compared to mesoderm-derived parietals. The latter were 
highly inefficient at making mineralized nodules in cul-
ture. However, the co-culture of parietal osteoblasts with 
neural crest-derived cells overcame this inefficiency, as 
the neural crest nucleated the bony nodules, allowing the 
mesodermal cells to engage in osteogenesis. This finding 
corroborates previous studies that report an ability of 
dura mater cells to provide a pro-osteogenic signal to cells 
in co-culture [Cooper et al., 2012].
 The neural crest-derived cranial populations also showed 
distinct cell-autonomous osteogenic potential in vitro. We 
compared the ALP activity and the presence of mineralized 
nodules in cultures of frontal bone osteoblasts, dura mater, 
and IFS progenitors. The dura mater, as expected, showed 
the highest osteogenic capacity, possibly accompanied by 
an increased proliferation, judging by the higher density of 
cells when compared to every other cranial population. 
Moreover, the cells derived from frontal bone osteoblasts 
displayed increased ALP activity in comparison to cells 
from IFS. This could be indicative of a differentiation delay 
in the cells of the suture, which is unsurprising if we assume 
that the frontal osteoblasts are fully differentiated when 
harvested from the bone chips, while the sutural mesen-
chyme is still uncommited to the osteogenic lineage. Could 
the cells from the suture then be inherently programmed to 
remain undifferentiated in the absence of a pro-osteogenic 
cue? Do these cells require the input from the dura mater to 
undergo osteogenesis? Are any other lineages of a common 
progenitor obtained in these cultures at the expense of os-
teogenic cells? Future studies should include molecular 
analysis in order to confirm the differentiation status of the 
neural crest-derived cells.
 The investigation of signalling cues is very important 
for understanding the pathophysiology of CS. A recent 
study, in fact, has identified a number of de novo muta-
tions in negative regulators of the Wnt, BMP, and Ras/
ERK pathways, occurring in non-syndromic midline CS 
patients [Timberlake et al., 2017]. These pathways, know-
ingly implicated in positive regulation of osteogenesis, 
are, among other signals previously studied [Ang et al., 
2010], good candidates for dura mater’s regulatory milieu 
in the context of suture patency and fusion. All together, 
our study identifies distinct populations of osteoprogeni-
tors in the cranial vault and provides a deeper under-
standing on the ossifying capabilities of these cells. Our 
hope is that this study will aid the comprehension of gen-
eral suture biology and pathogenesis.
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